Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Allergan |
---|---|
Information provided by: | Allergan |
ClinicalTrials.gov Identifier: | NCT00141882 |
Randomized double-masked clinical trial of memantine in patients with glaucoma
Condition | Intervention | Phase |
---|---|---|
Open-Angle Glaucoma |
Drug: memantine |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Study ID Numbers: | 192944-004 |
Study First Received: | August 31, 2005 |
Last Updated: | December 18, 2007 |
ClinicalTrials.gov Identifier: | NCT00141882 |
Health Authority: | United States: Food and Drug Administration |
Excitatory Amino Acids Dopamine Glaucoma Eye Diseases |
Glaucoma, Open-Angle Memantine Hypertension Ocular Hypertension |
Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Anti-Dyskinesia Agents Therapeutic Uses Physiological Effects of Drugs Antiparkinson Agents |
Excitatory Amino Acid Agents Dopamine Agents Central Nervous System Agents Pharmacologic Actions Excitatory Amino Acid Antagonists |